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Background: Multimorbidity, the co-occurrence of two or more chronic conditions, is common among older adults and
is known to be associated with high costs and gaps in quality of care. Population-based estimates of multimorbidity are
not readily available, which makes future planning a challenge. We aimed to estimate the population-based prevalence
and trends of multimorbidity in Ontario, Canada and to examine patterns in the co-occurrence of chronic conditions.
Methods: This retrospective cohort study includes all Ontarians (aged 0 to 105 years) with at least one of 16 common
chronic conditions. Descriptive statistics were used to examine and compare the prevalence of multimorbidity by age and
number of conditions in 2003 and 2009. The co-occurrence of chronic conditions among individuals with multimorbidity
was also explored.
Results: The prevalence of multimorbidity among Ontarians rose from 17.4% in 2003 to 24.3% in 2009, a 40% increase. This
increase over time was evident across all age groups. Within individual chronic conditions, multimorbidity rates ranged
from 44% to 99%. Remarkably, there were no dominant patterns of co-occurring conditions.
Conclusion: The high prevalence of multimorbidity and numerous combinations of conditions suggests that single,
disease-oriented management programs may be less effective or efficient tools for high quality care compared to
person-centered approaches.
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Chronic disease management has been identified as a key
health system concern among developed countries given
the rising prevalence and burden of chronic illness [1-3].
According to the World Health Organization, chronic dis-
eases have reached epidemic proportions and constitute the
leading causes of death in the world [3]. In Canada, 74% of
individuals aged 65+ reported having one or more of 11
chronic conditions in 2008 [4]. Improvements in survival
and an aging population are two key reasons that the preva-
lence of chronic disease and the likelihood of living with
more than one condition are expected to continue to rise
for the foreseeable future [5,6]. In addition, several lifestyle
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unless otherwise stated.use of alcohol and unhealthy diet have been identified as
important contributors to the incidence of chronic diseases
and multimorbidity [3,7]. In their study, Fortin et al. found
that the likelihood of multimorbidity was associated with
the number of unhealthy lifestyle factors [7].
The coexistence of two or more chronic conditions is
usually defined as multimorbidity [5,6,8-10]. Empirical
studies based on surveys and physician practice records
show that multimorbidity is highly prevalent and is the
norm, particularly for older adults who are known to be
the highest users of the health care system [11,12]. The
prevalence can reach between 3% and 98% depending on
the setting, data sources and sample characteristics such
as age [8,13-20]. Based on registry data collected on pa-
tients enlisted in 10 Dutch primary care practices, Uijen
and Van de Lisdonk [18] observed that multimorbidity
varied by age, sex, and socio-economic class. This study
also reported that the prevalence of 3 chronic conditions
increased by approximately 60% between 1985 and 2005entral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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300%. Barnett et al. [21] reported a prevalence of multimor-
bidity of 23% among patients registered with 314 medical
practices in Scotland. While a larger proportion of the popu-
lation over age 65 experienced multimorbidity, they found
that the absolute number of people with multimorbidity was
higher among those aged 65 or less [21]. In Canada, Agbor-
sangaya et al. [22] reported that age- and sex-standardized
prevalence of multimorbidity was 19.0% among a represen-
tative sample of adults 18+ in Alberta. A more recent study
in the US also concluded that multimorbidity was common
in the population reporting a prevalence of multimorbidity
of 23% among their study population in Minnesota [23].
Individuals with multimorbidity have multiple medical
and social problems, and both the type and number of con-
ditions exacerbate the consequences of multimorbidity
[10,20,24]. Multimorbidity has been associated with lower
health related quality of life, higher utilization of health care
services and prescribed medications, increased disability,
and mortality (2–6, 14, 20–22). However the phenomenon
of multimorbidity is not well understood [25-27]. To date
most studies have been based on patients enrolled in se-
lected settings [11,28] and population-based estimates are
not commonly available.
Although the challenges of efficiently and effectively
managing individuals with multimorbidity have been ac-
knowledged, the complexity of the problem is not well
understood [5,10,27,29]. In their review of studies evaluat-
ing the effectiveness of interventions, Smith et al. [30]
concluded that, “interventions targeted either at specific
combinations of common conditions or at specific prob-
lems for patients with multiple conditions, may be more
effective”. The authors also suggest focusing for example
on functional decline occurring with multimorbidity, ra-
ther than clinical management of specific diseases. As
pointed out by Boyd and Fortin [5], some concordant co-
occurring conditions may be managed synergistically,
whereas discordant conditions increase the complexity of
clinical care. In order to better inform approaches to care
management, there remains a need to identify the specific
clusters of conditions among individuals with multimor-
bidity, at a population-level.
The aims of this study were to: 1) estimate the
population-based prevalence and trends of multimor-
bidity across all age groups; and, 2) assess the co-
occurrence of chronic conditions and describe the most
common clusters across multimorbidity groupings. The
research also provides an opportunity to assess the use-
fulness of administrative databases to measure and con-
duct epidemiological research on multimorbidity.
Methods
This retrospective study used linked provincial health ad-
ministrative databases to identify the entire population ofOntario residents aged 0 to 105 years who were registered
and eligible for the province’s universal health insurance
in 2003 (n = 12,242,273) and 2009 (n = 13,068,845). People
were excluded if they fell under the following criteria: had
an invalid health card number, were older than 105 years
old, died before the index date, or had no contact with the
health care system in the last 5 years before the index date
(excepting infants). People with no contact with the
healthcare system within the past five years are suspected
to have either left the province or to have experienced an
unreported death.
Data sources
In Ontario, the costs of all medically necessary care are
covered by public health insurance funded from general
taxation. This includes all hospital and physician services
as well as some home care and long-term care services.
Drug coverage is provided to those aged 65 and over
and all residents who receive government social assist-
ance payments. All residents of the province are eligible
for this medical coverage, and immigrants receive ser-
vices after a three-month waiting period. Associated pro-
vincial health insurance claims databases offer a unique
opportunity to identify all individuals who used the
health care system and to retrieve information about
their medical conditions for inclusion in our cohort.
These data are housed and secured at the Institute for
Clinical Evaluative Sciences (ICES) under data security
and privacy policies and procedures that are approved
by the Office of the Information and Privacy Commis-
sioner of Ontario. We used these data to identify per-
sons with chronic conditions who had contact with the
healthcare system regardless of where they obtained
care. All datasets were linked using unique, encoded
identifiers and analyzed at the ICES.
Our cohorts were drawn from a series of linked health
administrative databases, not a single insurance file.
Ontario’s health care system typically provides services
by sector (ie. inpatient, drugs, physician services), and
the health administrative databases that capture this ser-
vice provision are distinct. Therefore, in order to assem-
ble a complete picture of the underlying diagnoses and
conditions of Ontarians, various health administrative
data were linked using unique encrypted identifiers at
the individual level. The Discharge Abstract Database
(DAD) consists of data from all hospital discharges in
Ontario and the Ontario Health Insurance Plan (OHIP)
claims database consists of billing claims for all phys-
ician encounters. Additionally, derived chronic condition
cohorts developed at ICES using linked data algorithms
were also considered [31-37]. These ICES cohorts have
been validated and derived from the key databases
(DAD, and OHIP claims). The Registered Persons Data-
base (RPDB) was used to identify Ontarians eligible for
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graphic information (namely age). Statistics Canada cen-
sus data were also used to derive population estimates
by age and sex in each year [38].
Identifying the chronic conditions
In order to be considered as cases, individuals were required
to have a history of at least one of 16 common chronic med-
ical conditions. We selected conditions based on their clin-
ical relevance and burden, both in terms of cost and
outcome (e.g. attributable deaths) as described in previous
literature [1-4,24,39,40]. These 16 conditions included: arth-
ritis (excluding rheumatoid arthritis), hypertension, asthma,
depression, diabetes, cancer, chronic coronary syndrome
(CCS), cardiac arrhythmia, osteoporosis, chronic obstructive
pulmonary disease (COPD), congestive heart failure (CHF),
renal failure, dementia, rheumatoid arthritis, stroke and
acute myocardial infarction (AMI). While this represents a
small number of possible conditions experienced by individ-
uals, it captures many of the most substantial conditions
from a population-based epidemiological perspective. Six of
these conditions (AMI, asthma, CHF, COPD, hypertension,
diabetes) were defined based on previously validated
population-derived ICES cohorts [31-37]. For the conditions
where a derived ICES cohort did not exist, we adopted a
similar approach to the derivation algorithms (i.e. at least
one diagnosis recorded in acute care, or two diagnoses re-
corded in physician records within a two-year period) to de-
fine the remaining chronic conditions: cancer, cardiac
arrhythmia, chronic coronary syndrome, dementia, depres-
sion, arthritis (excluding rheumatoid arthritis), osteoporosis,
renal failure, rheumatoid arthritis, and stroke. The full set
of diagnostic codes used to define the conditions is in-
cluded as Additional file 1. Multimorbidity was defined as
the co-occurrence of two or more of these conditions.
Analyses
We reported the prevalence of multimorbidity in the On-
tario population by age group, level of multimorbidity (2,
3, 4 and 5 or more conditions), and calendar year (2003
and 2009), by looking at concurrent frequencies. Thus, the
prevalence was estimated by dividing the number of indi-
viduals with multimorbidity by the total population.
We assessed clustering of chronic conditions in two ways.
First, for each selected condition, we measured the likeli-
hood of co-occurring with 1, 2, 3 and 4 or more other
conditions. The denominator was the total number of indi-
viduals with a specific condition and the numerator was the
number of individuals with the same condition plus 1, 2, 3
and 4 or more co-occurring conditions. Secondly, we de-
rived the five most common co-occurring clusters of condi-
tions within each level of multimorbidity (i.e. pairs, triads,
quartets, and quintets) and measured their prevalence
(number of individuals presenting the most commoncluster in the targeted level of multimorbidity divided by
the number of individuals in this level).
All data analyses were performed with SAS package
version 9.3 (SAS Institute, Cary, North Carolina).
The study received ethics approval by the Sunnybrook
Health Sciences Centre Review Board. Participants’ con-
sent was not necessary, as we used administrative data.
Results
Overall, 43% of the Ontario population had a history of
at least one of the selected chronic conditions in 2003
and 50.8% had a history of at least one condition in
2009 (Table 1). The proportions varied by age groups,
from 24.9% in those younger than 18 years to 92.4%
among those aged 90 or more in 2009. The prevalence
of multimorbidity was 24.3% in 2009 – an increase of
forty percent from 17.4% in 2003 (Table 1). The increas-
ing proportion of people with multiple conditions is a
concern for all age groups. For example, 2.2% of people
0 to 17 years and 10.6% of those 18 to 44 years had mul-
timorbidity in 2009 representing an increase of 57.1%
and 43.2% respectively compared to 2003 (Table 1). The
prevalence of 3 or more conditions also nearly doubled
between 2003 and 2009. The increase in multimorbidity
is remarkable given that the prevalence of having only
one condition remained relatively stable at approxi-
mately 26%.
The prevalence of each chronic condition for each year
is shown in Table 2. With the exception of depression and
AMI, the prevalence of each condition in 2009 was higher
than in 2003. The most prevalent conditions in the cohort
as of 2009 were osteoarthritis and other arthritis, hyper-
tension, asthma, depression, diabetes and cancer. However
the prevalence of each condition varied with age. Asthma
represented the most common condition among children
less than 18 years whereas hypertension or arthritis repre-
sented the most common conditions among those aged
45+ years (Table 2).
Figure 1 compares the trends of multimorbidity across
ages between 2003 and 2009. Multimorbidity is highly
prevalent in the oldest age groups, where more than 80% of
the population had at least two conditions in 2009 (i.e. al-
most the whole area under the curve for ages 75 or more).
While multimorbidity is most frequent in the oldest seg-
ments of the population, the prevalence is substantial even
among individuals aged 40 or less. Within sub-groups of in-
dividuals based on birth year, we observed increasing num-
bers of individuals with multimorbidity from 2003 to 2009.
For example, among individuals who were 56 years old in
2003, 48,101 had two or more conditions; six years later
81,046 of these individuals had two or more conditions.
Moreover, in 2003, there was no birth cohort (based on
year of birth) that included more than 100,000 people with
multimorbidity; but by 2009, there were 20 birth cohorts







Prevalence of at least
one chronic condition
Prevalence of multimorbidity, by degree of multimorbidity
Prevalence of multimorbidity, 2+
conditions
2 3 4 5 +
conditions
0-17 2 794 680 23.2 1.4 1.4 0.1 0.01 0.001
18-44 4 928 716 31.6 7.4 6.0 1.2 0.2 0.05
45-54 1 753 264 51.5 20.4 13.8 4.7 1.4 0.5
55-64 1 213 587 67.6 35.3 20.6 9.3 3.5 1.8
65-74 839 869 82.3 53.6 25.9 15.3 7.3 5.1
75-89 657 855 89.9 68.3 25.7 19.7 11.9 11.0
90+ 54 302 93.7 74.6 24.7 20.8 14.3 14.8






Prevalence of at least one chronic
condition
Prevalence of multimorbidity, by degree of multimorbidity
Prevalence of multimorbidity, 2+
conditions
2 3 4 5 +
conditions
0-17 2 732 548 24.9 2.2 2.0 0.2 0.01 0.001
18-44 4 951 761 38.6 10.6 8.2 1.9 0.4 0.1
45-54 2 065 338 60.0 27.4 17.2 6.9 2.3 1.0
55-64 1 527 927 76.6 46.6 23.8 13.4 5.9 3.5
65-74 941 352 88.9 66.4 26.1 19.8 11.3 9.2
75-89 775 760 94.0 80.9 21.4 22.0 16.6 20.9
90+ 74 159 92.4 83.2 17.1 20.0 18.2 27.8
All 13 068 845 50.8 24.3 12.3 6.2 3.1 2.7
*Arthritis (excluding rheumatoid arthritis), hypertension, asthma, depression, diabetes, cancer, chronic coronary syndrome (CCS), cardiac arrhythmia, osteoporosis,
chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), renal failure, dementia, rheumatoid arthritis, stroke and acute myocardial
infarction (AMI).
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above the line in Figure 1).
Figure 2 shows the prevalence of multimorbidity
within individuals with each chronic condition in 2003
and 2009. With the exception of asthma, which was
common in children younger than 18 years and thus
most likely to present as a single condition, other condi-
tions were unlikely to occur alone. In 2009, multimor-
bidity (at least one other condition) within individual
chronic conditions ranged from 44% (asthma) to 99%
(AMI). In 2009, the proportions of individuals with 4 or
more other conditions, ranged from 7.2% (asthma) to
60.8% (CHF).
Table 3 displays the top five most common diseases
pairs, triads, quartets, and quintets in 2009. We observed
many different combinations of co-occurring conditions
within each level of multimorbidity, and as the number of
conditions increased, the number of observed clusters in-
creased exponentially. Among those with only two condi-
tions, five possible combinations accounted for 50% of the
population with that level of multimorbidity. However,
243 unique combinations of quintets of conditions wererequired to capture the first fifty percent of individuals
with 5 or more conditions. The number of clusters re-
quired to include eighty percent of the population in-
creased from 14 (among individuals with two conditions)
to 2744 clusters of conditions (among individuals with 5
or more conditions). The five most prevalent clusters
accounted for only 6% to 52% of each level of multimor-
bidity. Even among people with only 2 or 3 conditions, we
observed a total of 113 and 443 different clusters repre-
sented among the study population (data not shown).
Mathematically, with the 16 conditions included in this
study, there are 120 and 560 possible combinations of 2
and 3 conditions.
Discussion
Our results show that multimorbidity is prevalent in the
population of Ontario; it has increased over time and re-
mains a concern in adult populations, including among indi-
viduals younger than 65. Among those with at least one of
the conditions examined, co-occurrence with multiple con-
ditions is the norm. Multimorbidity manifests differently
across individuals, as exhibited by the many different
Table 2 Population-based prevalence of 16 common chronic conditions in Ontario, by age group and year
Year Number with condition
(prevalence)
Prevalence of each condition, by age group
0-17 18-44 45-54 55-64 65-74 75-89 90+
Arthritis (except RA) 2003 1 248 116 (10.2) 1.5 6.8 13.9 18.4 23.7 26.4 21.5
2009 2 728 783 (20.9) 3.1 13.7 27.7 36.5 42.7 48.8 43.7
Hypertension 2003 1 989 338 (16.2) 0.2 4.6 18.9 35.5 55.4 64.6 57
2009 2 595 152 (19.9) 0.3 5.3 21.6 40.8 60.9 74.3 68.7
Asthma 2003 1 472 574 (12) 20.6 10.5 8.5 8.6 10.2 10.8 7.8
2009 1 823 345 (14) 20.5 14.2 10.5 10.4 11.2 12.2 9.9
Depression 2003 1 456 160 (11.9) 2.4 14.2 16.6 14.9 13.9 14.9 12.5
2009 1 409 054 (10.8) 2.2 12.5 14.9 14 11.9 12.3 9.7
Diabetes 2003 679 519 (5.6) 0.2 2 6.6 12.3 19 18.9 12.4
2009 1 043 016 (8) 0.3 2.6 8.8 16.6 24.7 26.5 17.4
Cancer 2003 725 971 (5.9) 0.9 3.4 7.1 10 16.4 19.1 12.6
2009 870 906 (6.7) 1 3.5 7.4 11 17.3 21 14.3
Chronic coronary 2003 375 830 (3.1) 0 0.3 2.1 6 12.8 18 16
syndrome 2009 625 600 (4.8) 0 0.4 3.1 8.6 17.3 26.7 26.4
Cardiac arrhythmia 2003 141 599 (1.2) 0 0.3 0.6 1.5 4.1 8.1 8.7
2009 307 447 (2.4) 0.1 0.7 1.5 3 6.7 14.3 17
Osteoporosis 2003 131 799 (1.1) 0 0.1 1 2.6 4.4 4.8 3.5
2009 287 798 (2.2) 0.1 0.2 1.3 4.8 8.1 10.7 9.6
COPD 2003 233 844 (1.9) 0 0.1 1.4 3.3 7.8 12.2 11.8
2009 257 012 (2) 0 0.1 1.3 3.3 7.1 11.8 12.4
CHF 2003 196 169 (1.6) 0 0 0.5 1.9 5.6 13.8 25.1
2009 216 172 (1.7) 0 0 0.5 1.9 5.1 13.2 23.4
Renal failure 2003 50 680 (0.4) 0 0.1 0.3 0.6 1.5 2.6 2.6
2009 149 234 (1.1) 0.1 0.3 0.7 1.5 3.5 6.9 7.4
Dementia 2003 88 894 (0.7) 0 0 0.1 0.3 1.4 7.9 22
2009 148 508 (1.1) 0 0.1 0.2 0.5 2 11.2 28.4
Rheumatoid arthritis 2003 68 279 (0.6) 0.1 0.3 0.7 1.2 1.6 1.8 1
2009 137 729 (1.1) 0.1 0.4 1.2 2.1 2.7 3.3 2.6
Stroke 2003 56 311 (0.5) 0 0.1 0.2 0.6 1.6 3.6 4.9
2009 124 199 (1) 0 0.1 0.5 1.2 2.9 6.5 9
AMI 2003 16 848 (0.1) NA 0 0.1 0.3 0.5 0.8 0.8
2009 13 032 (0.1) NA 0 0.1 0.2 0.3 0.5 0.7
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population-based results for Ontario contribute to epi-
demiological evidence regarding the prevalence of multi-
morbidity [4,11,12,21-23] and add unique information
regarding population-based trends. These findings have
many implications for care management and future
research.
Multimorbidity crosses age groups
Overall, we found that in 2009, one in four Ontarians
(24%) had at least two of the 16 conditions selected for
the study. This proportion reached more than three infour people (81%) among those aged 75 years or more.
The high prevalence of multimorbidity has also been re-
ported in other settings and populations, primarily among
older people. Like other studies [12,13,17,18,21,41], we
found that multimorbidity significantly increases with age.
While there is some (limited) evidence showing that
young adults and children may also be affected by multi-
morbidity [19,21,41], most research has focused on older
adults [5,9,18,19,42]. In our study, approximately 1.4% of
those aged less than 18 years had multimorbidity, and the
most common conditions in this age group were asthma,
arthritis (excluding rheumatoid arthritis), depression, and
Figure 1 Distribution of the number of individuals with multimorbidity in Ontario across ages, by number of common chronic conditions and year.
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years), multimorbidity varied from 7% to 35%, with most
common conditions being, arthritis (excluding rheuma-
toid arthritis), hypertension, asthma, depression, diabetes
and cancer. In older adults, besides arthritis, hypertension,
and diabetes, chronic coronary syndrome, dementia and
congestive heart failure are also highly common and con-
tribute to the elevated prevalence of multimorbidity.
While improved care and survival are likely the most im-
portant focus among older adults, healthy lifestyles and
other behavioural factors are also important areas to focus
on particularly among young and middle aged adults
[3,7,43]. Physical inactivity, alcohol abuse, and an un-
healthy diet have been reported as risk factors for chronic
conditions such as cancers, diabetes, hypertension [44].
These factors, which are increasingly prevalent among
young people [45,46], might contribute to the observed in-
creases in the prevalence of chronic conditions and multi-
morbidity. There is a need to continue to advocate for
prevention activities and healthy lifestyle and also find bet-
ter ways to care for individuals with multiple conditions,
regardless of their age.
Complexity of multimorbidity and the need of a
patient-centered approach
One of the more interesting findings is that while
single-disease prevalence has increased slightly, multi-
morbidity has increased significantly between 2003 and
2009 in Ontario. The increase in multimorbidity over the
6-year study period was 10 times higher than the increaseof any single condition. Very few studies have analyzed
trends over time in multimorbidity and/or illustrated trends
in single conditions compared to trends in multimorbidity
[18,47]. Uijen et al. [18] reported that the prevalence of sin-
gle chronic disease(s) was stable over the 20-year period of
their study, whereas there was a significant increase in mul-
timorbidity, specifically in those with three conditions
(67%) and four or more chronic diseases (288%). A similar
trend was reported by Paez et al. [47] in their study based
on self-reported data; there was a decrease in the preva-
lence of individuals with single conditions over ten years,
compared to an excess of 1.1 and 5.9 percentage points,
among those with two and three or more conditions re-
spectively. We found a more remarkable increase in our
study, as the prevalence almost doubled over the six-year
period, for those with three or more conditions in Ontario.
There are many potential reasons for this 40% increase in
the prevalence of multimorbidity including unhealthy be-
haviors as well as improved understanding of conditions
and advances in medical technology leading to longer sur-
vival and greater aptitude to live with many conditions
[3,7,43]. Additionally, the enhancements in the manage-
ment of administrative databases and improved tracking of
diagnoses may continuously contribute to a greater number
of individuals identified with any conditions overtime.
Our study also examined the clustering of conditions and
found that there was no common typology among individ-
uals with multimorbidity. Because most clinical programs
or guidelines for chronic disease management focus on spe-





















Figure 2 Distribution of the proportion of individuals with multimorbidity in Ontario, within common chronic conditions and by year.
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viduals with multimorbidity [5,10,48]. In order to inform
the management of individuals with multimorbidity, it is
crucial to identify the combinations of conditions among
those with multimorbidity, as addressed in this study. Our
findings highlighted the challenges in designing effective
disease-oriented management programs, as individuals with
multimorbidity do not exhibit dominant combinations of
conditions. Developing disease management programs for
individuals with multimorbidity will be challenging due to
the unmanageable number of clusters of medical condi-
tions. Among individuals with four conditions, the largest
cluster of conditions represents only 5% of that population,
while no distinct cluster has prevalence higher than 1.5%
among individuals with 5 or more conditions. This is adaunting prospect for clinicians aiming to manage these in-
dividuals in clinical practice. The number and variety of ob-
served clusters suggests that patient-centred care may be a
more appropriate generalized clinical approach [10].
Strengths and limitations
This retrospective population-based cohort study has many
strengths and some limitations in regard to the data
sources, case definitions and analytical methods, including
number of conditions selected or population coverage. The
primary limitation could be the use of administrative data
instead of definitive clinical information, but this also con-
stitutes a strength for our population-based study. Our
study relied on diagnoses recorded in hospitalization data
and physicians’ claims to identify people with each of 16
Table 3 Top five frequent clusters of co-occurring chronic conditions among Ontarians in 2009, by level of
multimorbidity
Frequency of co-existing chronic
conditions, within levels of
multimorbidity (Percent of population
within level of multimorbidity)
Percent of population included
in top 5 clusters among those with
this level of multimorbidity
Number of clusters accounting for:
50% of those
with this level of
multimorbidity
80% of those
with this level of
multimorbidity
2 conditions
(n = 1 603 837)
Hypertension & Arthritis (17.5%); 52.0% 5 14
Depression & Arthritis (10.0%);
Diabetes & Hypertension (9.0%);
Asthma & Arthritis (8.8%);
Asthma & Depression (6.6%)
3 conditions
(n = 816 612)
Diabetes & Hypertension & Arthritis (10.9%); 33.4% 11 45
Depression & Hypertension & Arthritis (6.8%);
Cancer & Hypertension & Arthritis (5.8%);
Coronary Syn. & Hypertension & Arthritis (5.0%);
Asthma & Hypertension & Arthritis (4.9%)
4 conditions
(n = 406 052)
Coronary Syndrome & Diabetes & Hypertension &
Arthritis (5.6%);
20.1% 30 127
Depression & Diabetes & Hypertension & Arthritis
(4.0%);
Asthma & Diabetes & Hypertension & Arthritis (3.8%);
Cancer & Diabetes & Hypertension & Arthritis (3.6%);
Asthma & Depression & Hypertension & Arthritis
(3.2%)
5+ conditions
(n = 348 129)
Asthma & Depression & Diabetes & Hypertension &
Arthritis (1.4%);
6.0% 243 2744
Cancer & Coronary S & Diabetes & Hypertension &
Arthritis (1.3%);
Coronary S & Depression & Diabetes & Hypertension
& Arthritis (1.2%);
CHF & Coronary S & Diabetes & Hypertension &
Arthritis (1.1%);
Asthma & Coronary S & Diabetes & Hypertension &
Arthritis (1.0%)
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been suggested as the best source for measuring multimor-
bidity, since they are more comprehensive [11,13]. This is
appropriate for individual clinical practices, but population-
based analyses require a less resource-intensive approach.
Administrative data have been demonstrated to be a rele-
vant alternative [49-51] and a combination of multiple
sources of data (hospital and physician) can contribute to
produce more reliable estimates. In our study, multiple da-
tabases were used to ascertain the cases, including hospital
stay (DAD), physician visits (OHIP), and validated disease
cohorts.
With appropriate cases definitions, health administra-
tive data can provide valid proxies of clinical status and
allow for a suitable estimation of the prevalence or sur-
veillance of chronic conditions [49,51]. An appropriate
estimation of the prevalence of multimorbidity depends
on the case definition (including selection of conditions),the source of information and the sampling or recruit-
ment strategies [52]. The present study included 16
diagnostic groupings. For six conditions, cases were
identified from ICES cohorts based on validated defini-
tions. Validation studies of algorithms used to create
ICES registries found sensitivity values from 72% (for
hypertension) to 91% (for diabetes). Specificity values
varied between 76.5% (for asthma) and 98% (for CHF)
[31-37]. A similar approach to case definition was used
for non-validated conditions.
In sum, the health administrative databases used in
this study have been shown to adequately identify dis-
eases with appropriate algorithms. Moreover the rules
for tracking the medical information and the rigorous
coding system ensure the accuracy and completeness of
the databases. In fact standardized diseases classification
and specific fee codes related to the provincial schedule
of benefits are being used.
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of providing information on individuals with multimorbid-
ity at the population level and over time. This study in-
cluded all of the Ontario population, including children
and adults at all ages and found that multimorbidity was a
significant concern for younger as well as older populations.
The cohort enabled by the use of administrative data also
provided sufficient numbers to rigorously assess the cluster-
ing of conditions. Thus, we were able to conclude that
multimorbidity is a complex matter with few dominant pat-
terns, even among those with two or three conditions. The
availability of data in an ongoing manner also creates the
possibility of assessing trends and evaluating the longitu-
dinal transitions among individuals with multimorbidity.
Future research with these data might detect particular tra-
jectories of disease incidences and lead to identification of
risk factors common to particular patterns of multimorbid-
ity. The meaningful findings (increasing trends and age pat-
terns), the multiplicity of data sources, the use of validated
registries and the substantial coverage of the population
provide some evidence that health administrative databases
and the selection of 16 prevalent conditions are useful for
measuring and monitoring multimorbidity in Ontario
population.
The selection of a limited number of conditions could
also be seen as a limitation. However, including all pos-
sible conditions is controversial and may be inaccurate
since some conditions can be strongly related or consti-
tute risk factors for others [15], leading to an overesti-
mated count. These 16 conditions have a very high
degree of overlap with those used in other studies on
multimorbidity [24,53]. Most authors usually refer to a
limited list of conditions of interest [8,25,29] while
others consider an open list of all possible conditions
[15,16,18,19,24]. Moreover, when using an open list, only
a few and specific conditions contribute the most to the
prevalence of multimorbidity [13,14,24,25]. van den
Akker and colleagues [19] reported that only a small
number of key conditions among a complete list of 335
different diagnoses contributed to the prevalence of mul-
timorbidity, such that adding more conditions to the key
conditions did not significantly alter the overall count of
individuals with multimorbidity. Fortin and colleagues
[11] concluded that it is preferable to use a list of at least
12 chronic diseases for measuring multimorbidity. Our
selection of conditions was based on population impact,
which is affected by population prevalence and the im-
pact of the conditions on health. The population health
impact of these conditions is well supported by previous
studies [1-4,24,39,40]. In their review of multimorbidity
indices, Diederichs et al. [54] recommend the inclusion
of at least 11 of the most common diagnoses. All of
these conditions were included in our study. Other re-
searchers could decide to include additional conditionsbut that is unlikely to affect the general conclusions of-
fered by the present study. In sum, the selection of the
16 conditions for our study constitutes a strength, con-
sidering the objective of studying the prevalence of mul-
timorbidity at the population level. The inclusion of
more conditions would likely not change the findings on
the relative increase in multimorbidity over time or the
lack of common clusters. However, extending the num-
ber of conditions (e.g. including more mental and phys-
ical impairments resulting from multiple chronic
conditions) would likely lead to slightly higher estimates
of the prevalence of multimorbidity and a greater com-
plexity (ie. level of multimorbidity and clusters). As
shown by McLean et al. [41] there is a higher likelihood
that considering more mental health conditions would
impact the prevalence and complexity of multimorbidity
in younger ages.
Our work and that of others emphasizes the need for
a more comprehensive approach to understanding mul-
timorbidity, which needs to take into account a greater
number of psychiatric conditions and social factors
which influence coping and management [54].
An appropriate understanding of multimorbidity also
needs to address the factors associated with this
phenomenon. Though our study focused on the differ-
ences related to age, there are many other factors, in-
cluding sex and socioeconomic status that contribute to
the burden of multimorbidity [18,21,22,41,55]. In future
analyses, the impact of sex and socioeconomic status on
the prevalence and complexity of multimorbidity will be
explored in greater detail.
Conclusion
We found that multimorbidity was highly prevalent in On-
tario and increased significantly between the two time pe-
riods examined. As expected, age was strongly associated
with multimorbidity. Perhaps unexpectedly, we found great
diversity rather than dominant combinations of chronic
conditions, suggesting that single disease-oriented manage-
ment programs may be less effective tools for high quality
care compared to person-centered approaches. The high
and increasing prevalence of multimorbidity observed in
this study confirm the need for health care providers to
focus on this issue and highlights the importance of evalu-
ating the impact of multimorbidity on health outcomes,
costs and quality of care. Finally, there is a growing need to
address care management, patient experience and costs. It
is important to explore the common problems (e.g. pain
management, functional decline) associated with multimor-
bidity, in order to inform decision making for recom-
mended practice approaches. Constituting one of the most
significant challenges for health care in the 21st century,
more research is needed and is taking place to evaluate the
determinants, outcomes and costs of multimorbidity.
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